---
figid: PMC8996410__12943_2021_1434_Fig3_HTML
figtitle: Proteolysis-targeting chimeras (PROTACs) in cancer therapy
organisms:
- Homo sapiens
- Mus musculus
- Severe acute respiratory syndrome coronavirus 2
pmcid: PMC8996410
filename: 12943_2021_1434_Fig3_HTML.jpg
figlink: /pmc/articles/PMC8996410/figure/Fig3/
number: F3
caption: PROTACs targeting cancer proliferation. In cell cycle regulation, some proteins
  (e.g. c-Myc, p21) act as accelerator or inhibitor to regulate CDK expression. CDKs
  and their chaperones phosphorylate retinoblastoma protein (Rb), thus releasing transcription
  factor E2F and promoting DNA replication. The RAS-RAF-MEK-ERK pathway also plays
  a central role in growth-promoting signaling and elicits cell cycle progression.
  These key elements in cancer proliferation can be targeted by diverse PROTACs (red
  arrow). Tumor-suppressor proteins are indicated in blue and oncogenic proteins are
  indicated in red. In the presented pathways, PROTACs have been developed targeting
  BRD4 [, ], CDK4/6 [, ], EGFR [, ], AURORA-A [], Raf [], BRD7/9 [, ], CDK2/5 [],
  ERK1/2 [], HER2 [], MEK1/2 [, ], Ras [] and Wee1 []
papertitle: Proteolysis-targeting chimeras (PROTACs) in cancer therapy.
reftext: Xinyi Li, et al. Mol Cancer. 2022;21:99.
year: '2022'
doi: 10.1186/s12943-021-01434-3
journal_title: Molecular Cancer
journal_nlm_ta: Mol Cancer
publisher_name: BioMed Central
keywords: PROTAC | Targeted cancer therapy | Ubiquitin-proteasome system | Protein
  degradation
automl_pathway: 0.9401024
figid_alias: PMC8996410__F3
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC8996410__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8996410__12943_2021_1434_Fig3_HTML.html
  '@type': Dataset
  description: PROTACs targeting cancer proliferation. In cell cycle regulation, some
    proteins (e.g. c-Myc, p21) act as accelerator or inhibitor to regulate CDK expression.
    CDKs and their chaperones phosphorylate retinoblastoma protein (Rb), thus releasing
    transcription factor E2F and promoting DNA replication. The RAS-RAF-MEK-ERK pathway
    also plays a central role in growth-promoting signaling and elicits cell cycle
    progression. These key elements in cancer proliferation can be targeted by diverse
    PROTACs (red arrow). Tumor-suppressor proteins are indicated in blue and oncogenic
    proteins are indicated in red. In the presented pathways, PROTACs have been developed
    targeting BRD4 [, ], CDK4/6 [, ], EGFR [, ], AURORA-A [], Raf [], BRD7/9 [, ],
    CDK2/5 [], ERK1/2 [], HER2 [], MEK1/2 [, ], Ras [] and Wee1 []
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Brd3
  - Brd2
  - Brd4
  - ac
  - Brd7
  - Brd9
  - Cdk6
  - Cdk4
  - Aurka
  - Egfr
  - Erbb2
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - Cdk1
  - Cdc2b
  - Cdk2
  - Cdc25c
  - Rasgrf1
  - ti
  - Wee1
  - ras
  - Hras
  - Kras
  - Rem1
  - Zhx2
  - Mapk3
  - Mapk1
  - Map2k1
  - BRD3
  - BRD2
  - BRD4
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - BRD7
  - BRD9
  - CCND1
  - CCND2
  - CCND3
  - CDK6
  - CDK4
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - E2F8
  - EGFR
  - ERBB2
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - CCNB1
  - CCNB2
  - CCNB3
  - CDK1
  - POLD1
  - CDK2
  - CCNE1
  - CCNE2
  - CDC25C
  - RASGRF1
  - CDC25A
  - CDC25B
  - WEE1
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAPK3
  - MAPK1
  - MAP2K1
---
